Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175727 | SCV000227265 | benign | not specified | 2015-10-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000879718 | SCV001022767 | likely benign | Peroxisome biogenesis disorder 11A (Zellweger) | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003480075 | SCV004224918 | uncertain significance | not provided | 2023-05-18 | criteria provided, single submitter | clinical testing | BS1 |
Breakthrough Genomics, |
RCV003480075 | SCV005256958 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004552975 | SCV004745043 | likely benign | PEX13-related disorder | 2022-02-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |